Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.61 |
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.44 |
| ▸ | TUBB | P07437 | 1/20 | 0.44 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.44 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.44 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.44 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.44 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.44 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.44 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.44 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.44 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2089114 | 0.86 | CA12 (0.65) | CA2CA12CA1CA7CA9 | |
| SCHEMBL2090982 | 0.86 | CA12 (0.65) | CA2CA12CA1CA7CA9 | |
| SCHEMBL2089132 | 0.82 | CA12 (0.41) | CA2CA12CA1CA7CA9 | |
| SCHEMBL5444296 | 0.79 | CA2 (0.61) | CA2CA12CA1CA7CA9 | |
| SCHEMBL7013645 | 0.78 | HIF1A (0.49) | CA2CA12CA1CA7CA9 | |
| 1,2,4-Trimethoxybenzene SCHEMBL29350371 | 0.77 | CA12 (1.00) | CA2CA12CA1CA7CA9 | |
| 1,2,4-Trimethoxybenzene SCHEMBL481491 | 0.77 | CA12 (1.00) | CA2CA12CA1CA7CA9 | |
| 1,2,4-Trimethoxybenzene SCHEMBL27777905 | 0.77 | CA12 (1.00) | CA2CA12CA1CA7CA9 | |
| SCHEMBL2093197 | 0.77 | ACHE (0.48) | CA9ALDH1A1ACHETUBB4ATUBB | |
| SCHEMBL27887830 | 0.76 | CA2 (0.70) | CA2CA12CA1CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116234813-A | Assays and reagents for characterizing MHCI peptide binding | 基因泰克公司 | 2023-06-06 | — | — | CN | claimed |
| US-5356914-A | Cognition activators | BEECHAM GROUP P.L.C. (GB) | 1994-10-18 | — | — | US | claimed |
| EP-0552213-A1 | 1,2,5,6-TETRAHYDROPYRIDINE OXIME DERIVATIVES | BEECHAM GROUP PLC (GB) | 1993-07-28 | — | — | EP | claimed |
| WO-1992006959-A1 | 1,2,5,6-TETRAHYDROPYRIDINE OXIME DERIVATIVES | BEECHAM GROUP PLC (GB) | 1992-04-30 | — | — | WO | claimed |
| CN-117897617-A | Assays and reagents for characterizing MHC II peptide binding | 基因泰克公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-108785305-A | The heterocycle inhibitor of glutaminase | 卡利泰拉生物科技公司 | 2018-11-13 | — | — | CN | disclosed |
| CN-107949387-A | With glutamine ihibitors for treatment lung cancer | 卡利泰拉生物科技公司 | 2018-04-20 | — | — | CN | disclosed |
| CN-107921031-A | The method for giving glutamine enzyme inhibitor | 卡利泰拉生物科技公司 | 2018-04-17 | — | — | CN | disclosed |
| EP-2719688-B1 | Process for producing tetrazolyloxime derivatives | NIPPON SODA CO (JP) | 2016-07-20 | — | — | EP | disclosed |
| EP-2719686-B1 | Process to halogenate a picoline derivative | NIPPON SODA CO (JP) | 2015-12-02 | — | — | EP | disclosed |
| EP-2719687-B1 | Process to make a bromopicoline derivative | NIPPON SODA CO (JP) | 2015-09-16 | — | — | EP | disclosed |
| US-9018385-B2 | Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative | NIPPON SODA CO., LTD. (JP) | 2015-04-28 | — | — | US | disclosed |
| EP-1695962-A1 | CYCLIC AMINE DERIVATIVE HAVING HETEROARYL RING | Sankyo Company, Limited (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-7030138-B2 | Benzamidine derivatives | SANKYO COMPANY, LIMITED (JP) | 2006-04-18 | — | — | US | disclosed |
| WO-2006035954-A1 | CARBOSTYRIL COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-04-06 | — | — | WO | disclosed |
| CN-1599640-A | Biopolymer synthesis substrate and method for producing biopolymers | MICRONAS GMBH (DE) | 2005-03-23 | — | — | CN | disclosed |
| US-20040147555-A1 | Benzamidine derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-07-29 | — | — | US | disclosed |
| EP-1375482-A1 | BENZAMIDINE DERIVATIVE | Sankyo Company, Limited (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-5356914-A | Cognition activators | BEECHAM GROUP P.L.C. (GB) | 1994-10-18 | — | — | US | disclosed |
| WO-1992006959-A1 | 1,2,5,6-TETRAHYDROPYRIDINE OXIME DERIVATIVES | BEECHAM GROUP PLC (GB) | 1992-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147555-A1 | Benzamidine derivatives | F9, F7, F2 | CA2 443/4885CA12 3204/4885CA1 2734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.